The Synbio Revolution is Here (REDUX)
I AM BIO
by Michael Koepke Chief Innovation Officer LanzaTech, Jennifer Wipf SVP and Head of Commercial Cell Engineering Ginkgo Bioworks, Matt Begemann Senior Director Gene Editing & Trait Discovery Benson Hill
1M ago
Innovative companies are using synthetic biology to engineer organisms and create new materials that could transform every sector of our economy, from health care to food and energy production. Those companies say we’ve entered a synbio revolution, and it holds potential to improve the health of people and our planet. In this episode, we talk with three synbio experts about how this convergence of genetic engineering, computer science and other scientific disciplines is making our world more sustainable.  Follow us on LinkedIn, X, Facebook and Instagram.  Visit us at https://www.bio ..read more
Visit website
How Biotechs Survive the Valley of Death (REDUX)
I AM BIO
by Nancy Simonian CEO Syros Pharmaceuticals, Daphne Zohar Founder & CEO PureTech Health
1M ago
For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the immense complexity of the biotech landscape are among the never-ending challenges faced by early stage biotechs. In this episode we talk with two biotech executives about what it’s like to struggle and survive in this rough-and-tumble industry.   Follow us on LinkedIn, X, Facebook and Instagram.  Visit us at https://www.bio ..read more
Visit website
Biotech Women Striking at the Glass Ceiling (REDUX)
I AM BIO
by Anna Rath CEO Vestaron, Erika Smith CEO ReNetX Bio, Grace Colón biotech executive entrepreneur and board member
2M ago
The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of a wave of women-led companies in biotech. Our guests speak to why women’s leadership matters and the barriers that remain to breaking the glass ceiling. They also tell us about a new networking initiative—the biotech sisterhood—to catalyze women’s success in corporate leadership and mentor the next generation of women executives.   Follow us on LinkedI ..read more
Visit website
We Need Bees. Bees Need Biotech. (REDUX)
I AM BIO
by Annette Kleiser CEO Dalan Animal Health, Andrey Zarur CEO GreenLight Biosciences, Kelly Bills Executive Director Pollinator Partnership
2M ago
Bees and other pollinators are critical to our survival, with one out of every three bites of food we eat depending on pollination to produce. That’s why reports of a decline in bee populations and rising threats from pests, viruses and environmental pressures, including climate change, are alarming. In this episode we talk with an expert on bees and other pollinators about how bees are doing and why it’s important to save them. We also talk with two biotech leaders whose companies are working to improve bee health through development of innovative treatments for some of the worst threats face ..read more
Visit website
The Horseshoe Crab Saved Us. Can We Save the Horseshoe Crab? (REDUX)
I AM BIO
by Deborah Cramer Science Writer and author of “The Narrow Edge”, Jay Bolden Director Global Laboratories Eli Lilly and Company, Lindsey Silva Director Microbiology Global QC Technology Genentech/Roche
3M ago
The horseshoe crab has endured for over 450 million years. It has survived several mass extinctions including the one that killed off the dinosaurs. One reason for their incredible resiliency is their ability to fend off bacterial infection. Their blood contains cells that clot around invading bacteria, thereby protecting them from the attacking toxins. In this episode we talk with three experts about how this animal’s unique blue blood has become essential to modern medicine. We also talk about why horseshoe crab populations are dwindling, and what biotech is doing to address the shortfall. F ..read more
Visit website
“On My Own”—Desperate to Stop a Resistant Bacterial Infection
I AM BIO
by Bradley Burnam Founder and CEO Turn Therapeutics, Kevin Outterson Executive Director CARB-X
3M ago
Bradley Burnam woke up one morning, looked in the mirror and found one ear twice it’s normal size and his face swollen and discolored. He would spend the next several years in and out of the hospital fighting a relentless infection that would not respond to available treatments. The experience took him from patient to mad scientist, to biotech company founder. In this episode, Bradley takes us through his desperate journey to find a cure. We also talk with the leader of an organization helping to get more antimicrobials to the marketplace. Follow us on LinkedIn, X, Facebook and Instagram.  ..read more
Visit website
The Synbio Revolution is Here
I AM BIO
by Matt Begemann Senior Director Gene Editing & Trait Discovery Benson Hill, Jennifer Wipf SVP and Head of Commercial Cell Engineering Ginkgo Bioworks, Michael Koepke Chief Innovation Officer LanzaTech
4M ago
Follow us on LinkedIn, X, Facebook and Instagram.  Visit us at https://www.bio.org/ Innovative companies are using synthetic biology to engineer organisms and create new materials that could transform every sector of our economy, from health care to food and energy production. Those companies say we’ve entered a synbio revolution, and it holds potential to improve the health of people and our planet. In this episode, we talk with three synbio experts about how this convergence of genetic engineering, computer science and other scientific disciplines is making our world more sustainable.&n ..read more
Visit website
How Biotechs Survive the Valley of Death
I AM BIO
by Daphne Zohar Founder & CEO PureTech Health, Nancy Simonian CEO Syros Pharmaceuticals
4M ago
Follow us on LinkedIn, X, Facebook and Instagram.  Visit us at https://www.bio.org/ For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the immense complexity of the biotech landscape are among the never-ending challenges faced by early stage biotechs. In this episode we talk with two biotech executives about what it’s like to struggle and survive in this rough-and-tumble industry.&nb ..read more
Visit website
Biotech Women Striking at the Glass Ceiling
I AM BIO
by Anna Rath CEO Vestaron, Grace Colón biotech executive entrepreneur and board member, Erika Smith CEO ReNetX Bio
5M ago
Follow us on LinkedIn, X, Facebook and Instagram.  Visit us at https://www.bio.org/ The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of a wave of women-led companies in biotech. Our guests speak to why women’s leadership matters and the barriers that remain to breaking the glass ceiling. They also tell us about a new networking initiative—the biotech sisterhood—to catalyze women’s success in corporate l ..read more
Visit website
The Horseshoe Crab Saved Us. Can We Save the Horseshoe Crab?
I AM BIO
by Jay Bolden Director Global Laboratories Eli Lilly and Company, Deborah Cramer Science Writer and author of “The Narrow Edge”, Lindsey Silva Director Microbiology Global QC Technology Genentech/Roche
6M ago
Follow us on LinkedIn, X, Facebook and Instagram.  Visit us at https://www.bio.org/ The horseshoe crab has endured for over 450 million years. It has survived several mass extinctions including the one that killed off the dinosaurs. One reason for their incredible resiliency is their ability to fend off bacterial infection. Their blood contains cells that clot around invading bacteria, thereby protecting them from the attacking toxins. In this episode we talk with three experts about how this animal’s unique blue blood has become essential to modern medicine. We also talk about why horses ..read more
Visit website

Follow I AM BIO on FeedSpot

Continue with Google
Continue with Apple
OR